Pain Therapeutics Granted $3.5M For Alzheimer’s Study, CEO Talks Micro-Cap Volatility – Benzinga

Benzinga
Pain Therapeutics, Inc. (NASDAQ: PTIE) is a micro-cap company that has developed several drug candidates, such as an abuse-resistant hydromorphone, an abuse-resistant hydrocodone and an antibody for metastatic melanoma.

and more

…read more

Source:: MicroCap Stock News From Google News

Leave a Comment